Intriguingly, Smac mimetics have shown broad preclinical activity in sensitizing cancer cells to TRAIL-induced apoptosis in vitro and in vivo in a variety of cancer entities,123, 124, 125, 126 rendering them promising candidates for efficient TRA-comprising therapeutic approaches. The gene discussed is TNFSF10; the disease is cancer.